We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENENTECH SAYS TRADE SECRET LAWS PREVENT APPROVAL OF BIOLOGICS
GENENTECH SAYS TRADE SECRET LAWS PREVENT APPROVAL OF BIOLOGICS
April 21, 2004
Approving a generic biologic would require the FDA to rely on an innovator firm’s trade secret data covering the product’s manufacturing process — something that is prohibited by law, argues biotech firm Genentech.